Abstract:Background: Intratympanic injections of glucocorticoids have become increasingly common in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL). However, due to their fast elimination, sustained applications have been suggested for local drug delivery to the inner ear. Materials and methods: The study is based on a retrospective chart review of patients treated for ISSHL at a single tertiary (university) referral center. We included patients who were treated with a solid, biodegradable, poly(D,L-lactic-co-glycolic acid) (PLGA)-based drug delivery system providing sustained delivery of dexamethasone extracochlear into the round window niche ( n = 15) or intracochlear into scala tympani ( n = 2) for tertiary therapy of ISSHL in patients without serviceable hearing after primary systemic and secondary intratympanic glucocorticoid therapy. We evaluated the feasibility and safety through clinical evaluation, histological examination, and functional tests [pure-tone threshold (PTA), word recognition scores (WRS)]. Results: With adequate surgical preparation of the round window niche, implantation was feasible in all patients. Histologic examination of the material in the round window niche showed signs of resorption without relevant inflammation or foreign body reaction to the implant. In patients where the basal part of scala tympani was assessable during later cochlear implantation, no pathological findings were found. In the patients with extracochlear application, average preoperative PTA was 84.7 dB HL (SD: 20.0) and 76.7 dB HL (SD: 16.7) at follow-up ( p = 0.08). The preoperative average maximum WRS was 14.6% (SD: 17.9) and 39.3% (SD: 30.7) at follow-up ( p = 0.11). Six patients (40%), however, reached serviceable hearing. The two patients with intracochlear application did not improve. Conclusion: The extracochlear application of the controlled release system in the round window niche and – based on limited observations - intracochlear implantation into scala tympani appears feasible and safe. Due to the uncontrolled study design, conclusions about the efficacy of the treatment are limited. These observations, however, may encourage the initiation of prospective controlled studies using biodegradable controlled release implants as drug delivery systems for the treatment of inner ear diseases.

Early Experience with a Novel Treatment for Menière's Disease: A Long Acting Dexamethasone Formulation for Precise Delivery to the Round Window Membrane

Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane

Study on Dexamethasone Thermosensistivie in Situ Gel for Treating Deafness

Long-term efficacy of dexamethasone treatment via tympanic antrum catheterization for intractable Meniere's disease

Consensus on Intra Tympanic Drug Delivery for Menière's Disease

Junctional Modulation of Round Window Membrane Enhances Dexamethasone Uptake into the Inner Ear and Recovery after NIHL

Silk-coated dexamethasone non-spherical microcrystals for local drug delivery to inner ear

Pharmacological Interventions for Menière's Disease: A Systematic Review and Network Meta-Analysis

Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone

Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear

Evaluation of a transtympanic delivery system in Mus musculus for extended release steroids

Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss

Repeated Courses of Intratympanic Dexamethasone Injection Are Effective for Intractable Meniere’s Disease

Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere's disease

Novel self-degradable prodrug blend thermogel for intratympanic drug delivery to treat inner ear diseases

Biopolymer Lipid Hybrid Microcarrier for Transmembrane Inner Ear Delivery of Dexamethasone

Microfluidic Preparation of Gelatin Methacryloyl Microgels As Local Drug Delivery Vehicles for Hearing Loss Therapy.

Clinical Evaluation of Intratympanic Methylprednisolone Perfusion for Intractable Meniere's Disease

Inner ear delivery of dexamethasone using injectable silk-polyethylene glycol (PEG) hydrogel

Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.

Remote-controlled dexamethasone-duration on eye-surface with a micelle-magnetic nanoparticulate co-delivery system for dry eye disease